Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Chembiochem : a European Journal of Chemical Biology|August 14, 2008
Supramolecular domains in mixed peptide self-assembled monolayers on gold nanoparticlesLaurence Duchesne, Geoff Wells, David G Fernig, et al.
Scientific Reports|September 6, 2017
Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagyNikolaos D Georgakopoulos, Michele Frison, Maria Soledad Alvarez, et al.
Free Radical Biology & Medicine|November 24, 2011
Peptide inhibitors of the Keap1-Nrf2 protein-protein interactionRowena Hancock, Hélène C Bertrand, Tadayuki Tsujita, et al.
Chemistry & Biology|December 3, 2014
PMI: a ΔΨm independent pharmacological regulator of mitophagyDaniel A East, Francesca Fagiani, James Crosby, et al.
Journal of Medicinal Chemistry|September 9, 2015
Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein InteractionHélène C Bertrand, Marjolein Schaap, Liam Baird, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2011
Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT boxFederico Brucoli, Rachel M Hawkins, Colin H James, et al.
Chemical Science|November 15, 2021
Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor designDénes Berta, Magd Badaoui, Sam Alexander Martino, et al.
Molecular Cancer Therapeutics|May 17, 2008
Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78Minal Kotecha, Jerome Kluza, Geoff Wells, et al.
Journal of Medicinal Chemistry|July 30, 2013
An extended pyrrolobenzodiazepine-polyamide conjugate with selectivity for a DNA sequence containing the ICB2 transcription factor binding siteFederico Brucoli, Rachel M Hawkins, Colin H James, et al.
Pageof 3